COCH
COM:ENVOYMEDICAL
Envoy Medical
- Stock
Last Close
2.20
22/11 21:00
Market Cap
44.10M
Beta: -
Volume Today
50.92K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | 530K - | 1.18M 122.17% | 1.35M 14.61% | ||
average payables | 378.35K - | 832K 119.90% | 1.28M 53.67% | ||
average receivables | 44K - | 64.50K 46.59% | 143.50K 122.48% | ||
book value per share | -4.43 - | -5.53 24.93% | -0.14 97.46% | ||
capex per share | -0.01 - | -0.02 74.40% | -0.01 43.23% | ||
capex to depreciation | -1.76 - | -2.91 65.10% | -1.15 60.42% | ||
capex to operating cash flow | 0.02 - | 0.02 37.38% | 0.01 65.00% | ||
capex to revenue | -0.40 - | -0.92 128.12% | -0.48 47.36% | ||
cash per share | 0.11 - | 0.02 83.68% | 0.34 1,764.36% | ||
days of inventory on hand | 503.12 - | 493.91 1.83% | 555.81 12.53% | ||
days payables outstanding | 313.74 - | 382.54 21.93% | 615.20 60.82% | ||
days sales outstanding | 103.61 - | 63.14 39.06% | 284.15 350.00% | ||
debt to assets | 9.12 - | 13.51 48.11% | 0.02 99.85% | ||
debt to equity | -0.53 - | -0.61 15.49% | -0.09 85.42% | ||
dividend yield | |||||
earnings yield | -0.09 - | -0.16 78.42% | -1.32 740.78% | ||
enterprise value | -25K - | 121.25M 485,106.85% | 136.09M 12.24% | 19.07M 85.99% | |
enterprise value over ebitda | -17.83 - | -15.77 11.57% | -1.05 93.37% | ||
ev to operating cash flow | -17.48 - | -15.46 11.59% | -1.08 93.01% | ||
ev to sales | 391.13 - | 574.22 46.81% | 60.36 89.49% | ||
free cash flow per share | -0.70 - | -0.89 27.79% | -1.42 59.63% | ||
free cash flow yield | -0.07 - | -0.09 24.22% | -0.78 783.40% | ||
graham net net | -4.52 - | -5.70 26.15% | -0.34 93.99% | ||
graham number | 9.23 - | 13.97 51.43% | 2.74 80.37% | ||
income quality | 0.80 - | 0.55 30.84% | 0.59 6.75% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | |||||
interest debt per share | 2.36 - | 3.40 44.27% | 0.01 99.63% | ||
inventory turnover | 0.73 - | 0.74 1.86% | 0.66 11.14% | ||
invested capital | -0.53 - | -0.61 15.49% | -0.09 85.42% | ||
market cap | 98.90M - | 101.74M 2.87% | 22.73M 77.66% | ||
net current asset value | -70.69K - | -45.15M 63,764.88% | -57.08M 26.42% | -2.58M 95.48% | |
net debt to ebitda | -3.29 - | -3.98 21.06% | 0.20 105.04% | ||
net income per share | -0.85 - | -1.57 83.55% | -2.38 51.93% | ||
operating cash flow per share | -0.68 - | -0.87 26.95% | -1.41 62.18% | ||
payables turnover | 1.16 - | 0.95 17.99% | 0.59 37.82% | ||
receivables turnover | 3.52 - | 5.78 64.09% | 1.28 77.78% | ||
research and ddevelopement to revenue | 12.71 - | 19.05 49.96% | 28.34 48.74% | ||
return on tangible assets | -3.31 - | -6.23 88.43% | -3.91 37.16% | ||
revenue per share | 0.03 - | 0.02 23.55% | 0.03 7.85% | ||
roe | 0.19 - | 0.28 46.92% | 16.97 5,887.50% | ||
roic | 0.33 - | 0.42 27.19% | 15.31 3,582.75% | ||
sales general and administrative to revenue | 7.98 - | 14.64 83.53% | |||
shareholders equity per share | -4.43 - | -5.53 24.93% | -0.14 97.46% | ||
stock based compensation to revenue | |||||
tangible asset value | 24.30K - | -44.96M 185,128.19% | -56.17M 24.93% | -1.76M 96.86% | |
tangible book value per share | -4.43 - | -5.53 24.93% | -0.14 97.46% | ||
working capital | -70.69K - | 1.05M 1,588.12% | -871K 182.79% | 189K 121.70% |
All numbers in USD (except ratios and percentages)